New Republic Capital’s Pfizer PFE Stock Holding History

New Republic Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$616K	Buy	25,574 +10,022	+64%	+$262K	0.14%	123
2026 Q1	$437K	Buy	15,552 +2,504	+19%	+$66.7K	0.15%	125
2025 Q4	$325K	Buy	+13,048	New	+$329K	0.09%	209
2024 Q4	–	Sell	-8,102	Closed	-$234K	–	249
2024 Q3	$234K	Sell	8,102 -1,928	-19%	-$56.2K	0.13%	142
2024 Q2	$281K	Buy	+10,030	New	+$276K	0.14%	131
2023 Q3	–	Sell	-7,749	Closed	-$284K	–	240
2023 Q2	$284K	Buy	7,749 +1,653	+27%	+$64.3K	0.2%	100
2023 Q1	$249K	Sell	6,096 -513	-8%	-$22.2K	0.19%	102
2022 Q4	$339K	Buy	+6,609	New	+$317K	0.27%	68

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

New Republic Capital's PFE Position: Q2 2026 in Review

New Republic Capital increased its Pfizer (PFE) stake by 64% in Q2 2026, buying an estimated $262K and bringing the position to 25,574 shares worth $616K. The position accounts for 0.14% of the portfolio, ranked #123.

New Republic Capital first reported a position in PFE in Q4 2022 and has held it in 8 quarters since. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

New Republic Capital held 25,574 shares of Pfizer worth $616K as of Q2 2026.
New Republic Capital bought 10,022 Pfizer shares in Q2 2026, an estimated $262K.
Pfizer made up 0.14% of New Republic Capital's portfolio in Q2 2026, its #123 holding.
New Republic Capital first reported a position in Pfizer in Q4 2022 and has held it in 8 quarters since.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.